Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PediaCare Chewables, New Luden’s Flavors Will Debut In August

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia is relaunching PediaCare Chewables with new indications and flavoring after discontinuing the brand in 1998, the firm said

You may also be interested in...



Pharmacia Luden's Acquisition Fuels Presence For Coming Cough/Cold Season

Pharmacia Consumer Healthcare will not oversee the manufacturing of Luden's throat drops until April; the company announced it had acquired the line from Hershey Foods Sept. 5.

PediaCare For Older Children, Sudafed Sinus Nighttime Debuting Late Summer

Pharmacia is launching two PediaCare line extensions in an attempt to "up-age" the venerable children's cough/cold line, the company said at the National Association of Chain Drug Stores Marketplace 2001 in Las Vegas June 28-July 2.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094211

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel